Biotin Anti-Human CD274/PD-L1 Antibody[29E.2A3]

Biotin Anti-Human CD274/PD-L1 Antibody[29E.2A3]

The Biotin Anti-Human CD274/PD-L1 Antibody[29E.2A3] is a cutting-edge product designed to facilitate advanced research in the field of immunology. This antibody is specifically engineered to target the CD274/PD-L1 protein, a crucial immune checkpoint molecule involved in regulating immune responses. With its high specificity and affinity, this antibody enables researchers to accurately detect and analyze the expression of CD274/PD-L1 in various biological samples.

This antibody is conjugated with biotin, a small molecule that allows for easy detection and visualization of the target protein. The biotinylated form of the antibody can be conveniently used in a variety of applications, including flow cytometry, immunohistochemistry, and western blotting. Its versatility makes it an invaluable tool for scientists studying the role of CD274/PD-L1 in diseases such as cancer, autoimmune disorders, and infectious diseases.

The Biotin Anti-Human CD274/PD-L1 Antibody[29E.2A3] has been rigorously tested for its performance and reliability. It exhibits minimal cross-reactivity with other proteins, ensuring accurate and specific results. Additionally, this antibody has been validated for use in multiple species, including human, mouse, and rat, broadening its applicability in diverse research settings. With its exceptional quality and extensive validation, this antibody is an indispensable resource for scientists seeking to unravel the complexities of immune regulation and develop novel therapeutic strategies.